ARKAY
Price
$85.00
Change
+$0.12 (+0.14%)
Updated
Feb 21 closing price
Capitalization
8.05B
4 days until earnings call
CSNVY
Price
$22.48
Change
-$0.77 (-3.31%)
Updated
Feb 10 closing price
Capitalization
1.39B
Ad is loading...

ARKAY vs CSNVY

Header iconARKAY vs CSNVY Comparison
Open Charts ARKAY vs CSNVYBanner chart's image
Arkema
Price$85.00
Change+$0.12 (+0.14%)
Volume$1.86K
Capitalization8.05B
Corbion
Price$22.48
Change-$0.77 (-3.31%)
Volume$200
Capitalization1.39B
ARKAY vs CSNVY Comparison Chart
Loading...
ARKAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARKAY vs. CSNVY commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARKAY is a Hold and CSNVY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ARKAY: $87.45 vs. CSNVY: $22.48)
Brand notoriety: ARKAY and CSNVY are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: ARKAY: 36% vs. CSNVY: 57%
Market capitalization -- ARKAY: $8.05B vs. CSNVY: $1.39B
ARKAY [@Chemicals: Specialty] is valued at $8.05B. CSNVY’s [@Chemicals: Specialty] market capitalization is $1.39B. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $223.16B to $0. The average market capitalization across the [@Chemicals: Specialty] industry is $9.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARKAY’s FA Score shows that 1 FA rating(s) are green whileCSNVY’s FA Score has 1 green FA rating(s).

  • ARKAY’s FA Score: 1 green, 4 red.
  • CSNVY’s FA Score: 1 green, 4 red.
According to our system of comparison, ARKAY is a better buy in the long-term than CSNVY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARKAY’s TA Score shows that 4 TA indicator(s) are bullish.

  • ARKAY’s TA Score: 4 bullish, 4 bearish.

Price Growth

ARKAY (@Chemicals: Specialty) experienced а +5.64% price change this week, while CSNVY (@Chemicals: Specialty) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -1.46%. For the same industry, the average monthly price growth was -2.13%, and the average quarterly price growth was -5.42%.

Reported Earning Dates

ARKAY is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Chemicals: Specialty (-1.46% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARKAY($8.05B) has a higher market cap than CSNVY($1.39B). CSNVY (14.31) and ARKAY (14.29) have similar P/E ratio . ARKAY YTD gains are higher at: 15.339 vs. CSNVY (-0.531). ARKAY has higher annual earnings (EBITDA): 1.41B vs. CSNVY (210M). ARKAY has higher revenues than CSNVY: ARKAY (10.4B) vs CSNVY (1.46B).
ARKAYCSNVYARKAY / CSNVY
Capitalization8.05B1.39B578%
EBITDA1.41B210M673%
Gain YTD15.339-0.531-2,889%
P/E Ratio14.2914.31100%
Revenue10.4B1.46B713%
Total Cash1.67BN/A-
Total Debt3.61BN/A-
FUNDAMENTALS RATINGS
ARKAY vs CSNVY: Fundamental Ratings
ARKAY
CSNVY
OUTLOOK RATING
1..100
493
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
30
Undervalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
8461
PRICE GROWTH RATING
1..100
4959
P/E GROWTH RATING
1..100
6057
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARKAY's Valuation (17) in the null industry is in the same range as CSNVY (30). This means that ARKAY’s stock grew similarly to CSNVY’s over the last 12 months.

ARKAY's Profit vs Risk Rating (97) in the null industry is in the same range as CSNVY (100). This means that ARKAY’s stock grew similarly to CSNVY’s over the last 12 months.

CSNVY's SMR Rating (61) in the null industry is in the same range as ARKAY (84). This means that CSNVY’s stock grew similarly to ARKAY’s over the last 12 months.

ARKAY's Price Growth Rating (49) in the null industry is in the same range as CSNVY (59). This means that ARKAY’s stock grew similarly to CSNVY’s over the last 12 months.

CSNVY's P/E Growth Rating (57) in the null industry is in the same range as ARKAY (60). This means that CSNVY’s stock grew similarly to ARKAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARKAY
RSI
ODDS (%)
Bearish Trend 6 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
56%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
59%
Advances
ODDS (%)
Bullish Trend 10 days ago
57%
Declines
ODDS (%)
Bearish Trend 21 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
55%
Aroon
ODDS (%)
Bullish Trend 6 days ago
68%
View a ticker or compare two or three
Ad is loading...
ARKAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ARKAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARKAY has been loosely correlated with BASFY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ARKAY jumps, then BASFY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARKAY
1D Price
Change %
ARKAY100%
-1.05%
BASFY - ARKAY
63%
Loosely correlated
-1.42%
AKZOY - ARKAY
58%
Loosely correlated
+0.53%
SXYAY - ARKAY
48%
Loosely correlated
-1.42%
JMPLY - ARKAY
46%
Loosely correlated
-0.96%
BNTGY - ARKAY
41%
Loosely correlated
+0.74%
More

CSNVY and

Correlation & Price change

A.I.dvisor tells us that CSNVY and BIOA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSNVY and BIOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSNVY
1D Price
Change %
CSNVY100%
N/A
BIOA - CSNVY
32%
Poorly correlated
-8.56%
IRLCF - CSNVY
25%
Poorly correlated
N/A
ARKAY - CSNVY
21%
Poorly correlated
-1.05%
NNOMF - CSNVY
21%
Poorly correlated
+1.41%
CLZNY - CSNVY
15%
Poorly correlated
N/A
More